Telsey Advisory Group Reaffirms "Outperform" Rating for Bath & Body Works (NYSE:BBWI)

Telsey Advisory Group reaffirmed their outperform rating on shares of Bath & Body Works (NYSE:BBWI - Free Report) in a report released on Friday, Benzinga reports. The brokerage currently has a $53.00 price target on the stock.

BBWI has been the subject of several other reports. BMO Capital Markets raised their target price on shares of Bath & Body Works from $48.00 to $50.00 and gave the company an outperform rating in a research note on Friday, March 1st. Evercore ISI raised their target price on shares of Bath & Body Works from $30.00 to $45.00 and gave the company an in-line rating in a research note on Friday, March 1st. Barclays downgraded shares of Bath & Body Works from an overweight rating to an equal weight rating and raised their target price for the company from $37.00 to $45.00 in a research note on Thursday, January 4th. The Goldman Sachs Group raised their target price on shares of Bath & Body Works from $49.00 to $56.00 and gave the company a buy rating in a research note on Monday, March 4th. Finally, Robert W. Baird lifted their price objective on shares of Bath & Body Works from $50.00 to $54.00 and gave the stock an outperform rating in a research note on Friday, March 1st. One analyst has rated the stock with a sell rating, seven have issued a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, Bath & Body Works currently has an average rating of Hold and a consensus price target of $45.80.

Bath & Body Works Stock Up 0.7 %

Bath & Body Works stock traded up $0.32 during midday trading on Friday, reaching $45.49. The stock had a trading volume of 5,381,520 shares, compared to its average volume of 2,816,635. Bath & Body Works has a 52-week low of $27.30 and a 52-week high of $50.34. The firm has a market cap of $10.23 billion, a price-to-earnings ratio of 11.82, a price-to-earnings-growth ratio of 1.55 and a beta of 1.86. The company has a fifty day moving average of $45.89 and a 200 day moving average of $39.29.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its earnings results on Thursday, February 29th. The company reported $2.06 EPS for the quarter, topping analysts' consensus estimates of $1.85 by $0.21. The business had revenue of $2.91 billion for the quarter, compared to analyst estimates of $2.84 billion. Bath & Body Works had a net margin of 11.82% and a negative return on equity of 37.01%. The company's quarterly revenue was up .8% compared to the same quarter last year. During the same period last year, the company posted $1.86 earnings per share. Equities research analysts predict that Bath & Body Works will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 8th. Shareholders of record on Friday, February 23rd were given a $0.20 dividend. The ex-dividend date was Thursday, February 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.76%. Bath & Body Works's dividend payout ratio (DPR) is currently 20.78%.

Insiders Place Their Bets

In related news, insider Thomas E. Mazurek sold 4,285 shares of the company's stock in a transaction dated Wednesday, March 27th. The shares were sold at an average price of $48.89, for a total transaction of $209,493.65. Following the completion of the transaction, the insider now owns 45,992 shares in the company, valued at approximately $2,248,548.88. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 0.19% of the company's stock.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of BBWI. Federated Hermes Inc. raised its holdings in Bath & Body Works by 17.1% in the 4th quarter. Federated Hermes Inc. now owns 1,612 shares of the company's stock valued at $70,000 after acquiring an additional 235 shares during the last quarter. Comerica Bank raised its holdings in Bath & Body Works by 0.9% in the 4th quarter. Comerica Bank now owns 33,091 shares of the company's stock valued at $1,428,000 after acquiring an additional 280 shares during the last quarter. Captrust Financial Advisors raised its holdings in Bath & Body Works by 10.4% in the 1st quarter. Captrust Financial Advisors now owns 3,124 shares of the company's stock valued at $149,000 after acquiring an additional 295 shares during the last quarter. Toroso Investments LLC raised its holdings in Bath & Body Works by 3.7% in the 3rd quarter. Toroso Investments LLC now owns 8,943 shares of the company's stock valued at $292,000 after acquiring an additional 319 shares during the last quarter. Finally, EverSource Wealth Advisors LLC raised its holdings in Bath & Body Works by 72.0% in the 4th quarter. EverSource Wealth Advisors LLC now owns 805 shares of the company's stock valued at $35,000 after acquiring an additional 337 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company's stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.